2017年8月
Safety and efficacy of anti-influenza drugs, intravenous peramivir against influenza virus infection in elderly patients with underlying disease
JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION
- ,
- ,
- ,
- 巻
- 50
- 号
- 4
- 開始ページ
- 541
- 終了ページ
- 544
- 記述言語
- 英語
- 掲載種別
- 研究論文(学術雑誌)
- DOI
- 10.1016/j.jmii.2016.11.006
- 出版者・発行元
- ELSEVIER TAIWAN
We retrospectively analyzed data of 38 elderly patients, each with an underlying disease, to evaluate peramivir safety and efficacy. Six patients (15.8%) experienced adverse events, all tolerated. Median time from administration until the return to normal temperatures was 31.5 h (95% CI: 22.4-40.6). Results confirm intravenous peramivir's usefulness. Copyright (C) 2017, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC.
- リンク情報
- ID情報
-
- DOI : 10.1016/j.jmii.2016.11.006
- ISSN : 1684-1182
- eISSN : 1995-9133
- PubMed ID : 28720319
- Web of Science ID : WOS:000411634300021